India Meditech Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 25-06-2024
- Paid Up Capital ₹ 1.98 Cr
as on 25-06-2024
- Company Age 28 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 10.19 Cr
as on 25-06-2024
- Revenue 25.36%
(FY 2022)
- Profit 32.74%
(FY 2022)
- Ebitda 36.30%
(FY 2022)
- Net Worth -54.81%
(FY 2022)
- Total Assets -10.99%
(FY 2022)
About India Meditech
The Corporate was formerly known as Prasang Steels Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 1.98 Cr.
The company currently has active open charges totaling ₹10.19 Cr.
Sanjeev Kumar and Vimal Khemka serve as directors at the Company.
- CIN/LLPIN
U74999DL1996PTC075408
- Company No.
075408
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Jan 1996
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
South Delhi, Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at India Meditech?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sanjeev Kumar  | Additional Director | 03-Jul-2020 | Current |
| Vimal Khemka | Director | 21-Jan-2012 | Current |
Financial Performance and Corporate Structure Insights of India Meditech.
India Meditech Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 25.36% increase. The company also saw a substantial improvement in profitability, with a 32.74% increase in profit. The company's net worth observed a substantial decline by a decrease of 54.81%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of India Meditech?
In 2021, India Meditech had a promoter holding of 21.19% and a public holding of 78.81%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
21 years 11 months Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 09 Oct 2020 | ₹3.74 Cr | Open |
State Bank Of India Creation Date: 01 Nov 2014 | ₹5.46 Cr | Open |
State Bank Of India Creation Date: 11 May 2012 | ₹9.88 M | Open |
How Many Employees Work at India Meditech?
India Meditech has a workforce of 17 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
As of Jun 21, 2017, India Meditech has raised a total of ₹ 6.08 Cr, with the most recent deal valued at ₹ 1.2 Cr. Access detailed insights into the company’s deals, including security allotments, mergers, acquisitions, and strategic partnerships that have shaped its growth.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
